**This position has a shift start time of 0700-1200, Monday to Friday, and rotates through a 0600-1100 Sunday shift once every 4 weeks.** The successful candidate will provide support at the Cross Cancer Institute laboratory by collecting and processing quality specimens for analysis. The primary responsibilities of the Laboratory Assistant I includes collection of blood specimens from cancer care patients and performing ECGs. The Cross Cancer Institute laboratory has a robust Outpatient Collection Department and also provides service to the Inpatient Unit and various Ambulatory Clinics.
As a Medical Laboratory Assistant I, you will provide high quality service to clients of the clinical laboratory in an effective, efficient and safe manner. You will be responsible for a variety of laboratory functions including procurement, handling, processing, dispatching and testing of specimens, performing procedures and reporting results.
- Classification: Laboratory Assistant I
-
Union: HSAA FAC PROF/TECH
-
Unit and Program: Laboratory
-
Primary Location: Cross Cancer Institute
-
Location Details: As Per Location
-
Multi-Site: Not Applicable
-
FTE: 0.65
-
Posting End Date: 02-JUL-2026
-
Temporary Employee Class: Temp P/T Benefits
-
Date Available: 27-JUL-2026
-
Temporary End Date: 25-JUL-2027
-
Hours per Shift: 5
-
Length of Shift in weeks: 2
-
Shifts per cycle: 10
-
Shift Pattern: Days, Evenings, Weekends
-
Days Off: As Per Rotation
-
Minimum Salary: $25.16
-
Maximum Salary: $31.36
-
Vehicle Requirement: Not Applicable
Required Qualifications:
Completion of an accredited Medical Laboratory Assistant program or equivalent.
Additional Required Qualifications:
Must have a recent demonstrated experience - practicum or working experience - with performing phlebotomy and ECGs within the last year (12 months).
Preferred Qualifications:
Demonstrated experience with EPIC Beaker - practicum or working experience - within the last year is strongly preferred. Demonstrated experience with collecting research kits and performing collections for clinical trials is preferred.
